Date
Category
NAD+ is a dinucleotide coenzyme. It is not a peptide: it carries no peptide bonds and no amino acid residues, and it is assembled from two nucleotides joined tail to tail through their phosphate groups, one carrying adenine and one carrying nicotinamide.
The compound appears in research catalogues beside peptides, and it is often filed under the same heading. That shelving decision follows how material is supplied. It says nothing about how the molecule is built, and the distinction matters the moment a researcher starts reading analytical documentation, because a coenzyme and a peptide are verified by different methods and fail in different ways.
All Janera Science compounds are supplied strictly for in-vitro laboratory research use only. They are not for human or veterinary use and have not been evaluated by the FDA.
[IMAGE: Hero, 16:9. Abstract rendering of the NAD+ dinucleotide, two ribose-linked bases joined through a phosphate bridge, in the Janera palette of deep navy, accent blue and white, no text, no laboratory glassware. ALT: Abstract rendering of the NAD+ dinucleotide structure showing two nucleotides joined through a phosphate bridge in blue and white]
At Janera Science, every compound is defined first by its chemistry. NAD+ is the clearest case in the catalogue of a molecule whose common shorthand obscures what it actually is, so it is worth taking apart properly.
What NAD+ Is: A Dinucleotide Coenzyme
NAD+ is nicotinamide adenine dinucleotide, a coenzyme that mediates redox reactions by transferring electrons between its oxidized and reduced forms. Published work describes NAD as an essential cofactor that mediates various redox reactions through the transfer of electrons between NAD+, the oxidized form, and NADH, the reduced form (Scientific Reports, 2019).
A dinucleotide is exactly what the name describes: two nucleotides bonded together. Each nucleotide contributes a nitrogenous base, a ribose sugar, and a phosphate group, and the two phosphates join in the middle to form a pyrophosphate bridge.
The two halves of the molecule
One half is adenosine monophosphate. Its base is adenine, the same base found in DNA and RNA, attached to a ribose sugar carrying a phosphate.
The other half is nicotinamide mononucleotide. Its base is nicotinamide, the amide of nicotinic acid, attached to its own ribose and phosphate.
The nicotinamide ring is where the chemistry happens. Adenine does not participate in the electron transfer, and its role is recognition, giving enzymes a handle to bind and orient the molecule correctly.
The plus sign is not a typo
The notation NAD+ refers to the formal positive charge on the nitrogen of the nicotinamide ring in the oxidized state. That quaternary nitrogen is what makes the ring able to accept a hydride ion.
Writing the compound as NAD without the sign is common shorthand and refers to the same molecule, usually in its oxidized form. Reading a chemical name from its notation is a small skill that pays off across documentation, and our guide to peptide nomenclature covers the equivalent conventions on the peptide side.
Why NAD+ Is Not a Peptide
A peptide is a chain of amino acids joined by peptide bonds. NAD+ contains neither. The two molecule classes share no structural feature beyond both containing nitrogen, and they are built, verified, and stored by different means.
A peptide bond is the amide linkage formed between the carboxyl group of one amino acid and the amino group of the next. Every peptide in a research catalogue, from a heptapeptide such as Semax to a longer sequence, is defined by that repeating backbone.
NAD+ has no backbone of that kind. Its two halves are joined by a phosphoanhydride bond between phosphate groups, which is the same linkage found in ATP and an entirely different piece of chemistry from an amide.
Where the naming confusion comes from
The compound is supplied to the same laboratories, in the same lyophilized vial format, and reconstituted in the same way as many research peptides. Catalogue structure follows the customer rather than the periodic table, so NAD+ ends up filed alongside compounds it has no chemical relationship to.
The practical cost of the shorthand shows up in documentation. A researcher who expects peptide-style verification will look for a sequence, and a coenzyme does not have one.
Property | Peptides | NAD+ |
|---|---|---|
Building blocks | Amino acids | Two nucleotides |
Key linkage | Peptide bond, an amide | Phosphoanhydride bridge |
Identity is defined by | Residue sequence | Molecular formula and structure |
Confirmed on documentation by | Sequence plus mass spectrometry | Mass, purity by HPLC, and CAS number |
Characteristic impurities | Deletions, truncations, oxidation | Hydrolysis products, the reduced form |
The Molecular Identity of NAD+
The table below lists the identity data that appears on analytical documentation for the compound. Every figure comes from the public chemical record rather than from a supplier description.
Property | Value |
|---|---|
Chemical name | Nicotinamide adenine dinucleotide |
Compound class | Dinucleotide coenzyme |
Molecular formula | C21H27N7O14P2 (PubChem, 2026) |
Molecular weight | 663.4 g/mol |
CAS number | 53-84-9 |
PubChem CID | 5892 |
Oxidized form | NAD+ |
Reduced form | NADH |
The CAS number is the piece worth noting. A registry number gives a compound a single unambiguous identifier that survives every naming variant it picks up in the literature, and our guide to CAS numbers explains how to verify one.
The NAD+ and NADH Redox Couple
NAD+ and NADH are the oxidized and reduced forms of the same molecule, and they interconvert by the transfer of a hydride ion. This pairing is what a redox couple means, and it is the function the coenzyme is named for.
When the nicotinamide ring accepts a hydride, two electrons and a proton, the ring loses its positive charge and the molecule becomes NADH. When NADH gives that hydride to another molecule, it reverts to NAD+.
Nothing is consumed in the redox cycle
The important structural point is that the molecule is not used up in this role. It cycles between the two states repeatedly, which is what distinguishes a coenzyme from a substrate.
That cycling is why the ratio between the two forms is the measurement that carries meaning in metabolic studies. The absolute quantity of either form says considerably less.
Why the two forms are analytically distinct
NAD+ and NADH differ by two electrons and a proton, so they differ in mass and in ultraviolet absorbance. NADH absorbs at 340 nanometres and NAD+ does not, which is the basis of a large body of enzyme assay work.
For a supplier, that difference is a purity question. Material sold as NAD+ that has partially reduced during handling is measurably different from material that has not, and the two forms resolve separately by chromatography.
Where the Molecule Is Genuinely Consumed
Redox cycling is not the whole picture. A second family of reactions breaks the molecule apart rather than recycling it, and those reactions are why cells must continually resynthesize it.
In these non-redox reactions, NAD+ is a substrate for several enzyme families, principally the sirtuins and the poly-ADP-ribose polymerases (Cells, 2022). These enzymes use NAD+ as an ADP-ribose donor, releasing nicotinamide as the catabolic product.
The structural consequence is direct. The glycosidic bond between nicotinamide and its ribose is cleaved, the ADP-ribose portion is transferred to a target, and the molecule no longer exists as NAD+. This is consumption in the literal sense, and it sets up the biosynthesis question.
How Cells Rebuild It: The Salvage Pathway
Because the non-redox reactions destroy the molecule, cells maintain routes to make more. The dominant route recycles the nicotinamide that those reactions release.
The salvage pathway is the main source of NAD+ generated in mammalian cells, owing to its high production efficiency, and its first step is the rate-limiting reaction catalysed by NAMPT, which converts nicotinamide to nicotinamide mononucleotide (Cells, 2022). A second enzyme then joins that intermediate to an adenine nucleotide to complete the dinucleotide.
A separate de novo route builds the nicotinamide ring from tryptophan rather than recycling it. It contributes far less of the total in most tissues, which is why the salvage route receives most of the attention in the literature.
Handling and Analytical Considerations
The chemistry above has direct consequences for how the material behaves in a vial, and they differ from the ones that govern a peptide.
Two distinct instabilities
NAD+ carries a phosphoanhydride bridge and a glycosidic bond, and both are hydrolysable. Material in solution is therefore less stable than material held as a dry powder, which is the same principle that makes lyophilization the standard format for research compounds.
The redox state is the second variable. Because NAD+ and NADH interconvert, the oxidized form can pick up reducing equivalents from its environment, so the assay-relevant question is the ratio of the two forms rather than a single purity figure. General handling practice for lyophilized research material applies here as well, and our guide to peptide storage and stability covers the temperature and moisture principles that carry across.
What documentation should show
Because the molecule has no sequence, identity confirmation rests on the molecular formula, the mass, and the CAS number rather than on a sequence readback. Purity is determined chromatographically in the same way it is for a peptide, and the same caution about co-elution applies, as set out in our guide to reading a certificate of analysis.
Third-party analytical documentation is published for every batch supplied, including material sold as NAD+.
Frequently Asked Questions
Is NAD+ a peptide?
No. NAD+ is a dinucleotide coenzyme built from two nucleotides joined by a phosphate bridge. It contains no amino acids and no peptide bonds, and it is only grouped with peptides in supply catalogues rather than by any chemical relationship.
What does the plus sign in NAD+ mean?
It denotes the formal positive charge carried by the nitrogen of the nicotinamide ring in the oxidized state. That charge is what allows the ring to accept a hydride ion and become NADH.
What is the difference between NAD+ and NADH?
They are the oxidized and reduced forms of the same molecule. NAD+ accepts a hydride to become NADH, and NADH donates it to revert to NAD+, so the pair functions as a redox couple rather than as two separate compounds.
What is the molecular formula of NAD+?
C21H27N7O14P2, with a molecular weight of 663.4 g/mol and CAS number 53-84-9 (PubChem, 2026).
Why do cells need to resynthesize NAD+ if it is a coenzyme?
Redox cycling does not consume the molecule, but a second group of enzymes, including the sirtuins and the poly-ADP-ribose polymerases, use it as a substrate and cleave it, releasing nicotinamide. That consumption is why the salvage pathway exists.
How is NAD+ verified analytically?
By molecular formula and mass rather than by sequence, since it has none, with purity determined chromatographically. The CAS number provides an unambiguous identity reference that is independent of naming variants in the literature.
Key Takeaways
NAD+ is a dinucleotide coenzyme, built from an adenine nucleotide and a nicotinamide nucleotide joined by a phosphoanhydride bridge. It contains no peptide bonds and is not a peptide.
The nicotinamide ring does the chemical work. Its positively charged nitrogen accepts a hydride to form NADH, and the adenine half serves enzyme recognition rather than the reaction itself.
Redox cycling does not consume the molecule, but sirtuins and poly-ADP-ribose polymerases do, cleaving it to donate ADP-ribose and releasing nicotinamide (Cells, 2022).
The salvage pathway is the main source of NAD+ in mammalian cells, and NAMPT catalyses its rate-limiting first step (Cells, 2022).
Identity documentation for a coenzyme rests on formula, mass, and CAS number rather than on a sequence, which is the practical reason the peptide comparison matters when reading a certificate of analysis.
All Janera Science compounds are supplied strictly for in-vitro laboratory research use only. They are not for human or veterinary use and have not been evaluated by the FDA.
Verify Every Batch
Janera Science publishes third-party Certificates of Analysis for the compounds it supplies. To review identity, purity, and analytical verification for current material, visit our lab results page. For the regulatory context behind how these materials are supplied, see our overview of what Research Use Only means.
